<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>5366</billNumber>
    <updateDate>2018-11-09T00:09:31Z</updateDate>
    <cboCostEstimates />
    <policyArea>
      <name>Taxation</name>
    </policyArea>
    <titles>
      <item>
        <chamberCode />
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Alzheimer's Breakthrough Sunshine Act</title>
      </item>
      <item>
        <chamberCode />
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>To amend the Internal Revenue Code of 1986 to exclude from gross income for seven years amounts earned from the sale of drugs that demonstrate breakthrough therapies for treating Alzheimer's disease.</title>
      </item>
      <item>
        <chamberCode />
        <chamberName />
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Alzheimer's Breakthrough Sunshine Act</title>
      </item>
    </titles>
    <introducedDate>2016-05-26</introducedDate>
    <version>1.0.0</version>
    <createDate>2016-05-27T05:26:27Z</createDate>
    <congress>114</congress>
    <originChamber>House</originChamber>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 162, Number 84 (Thursday, May 26, 2016)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. MURPHY of Florida:H.R. 5366.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 of the United States Constitution.[Page H3296]</pre>]]></constitutionalAuthorityStatementText>
    <laws />
    <billType>HR</billType>
    <title>Alzheimer's Breakthrough Sunshine Act</title>
    <committeeReports />
    <cosponsors>
      <item>
        <sponsorshipDate>2016-05-26</sponsorshipDate>
        <state>PA</state>
        <district>8</district>
        <identifiers>
          <gpoId>8126</gpoId>
          <lisID>1797</lisID>
          <bioguideId>F000451</bioguideId>
        </identifiers>
        <party>R</party>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <bioguideId>F000451</bioguideId>
        <middleName>G.</middleName>
        <lastName>Fitzpatrick</lastName>
        <fullName>Rep. Fitzpatrick, Michael G. [R-PA-8]</fullName>
        <firstName>Michael</firstName>
      </item>
    </cosponsors>
    <summaries>
      <billSummaries>
        <item>
          <actionDate>2016-05-26</actionDate>
          <lastSummaryUpdateDate>2016-06-03T12:15:13Z</lastSummaryUpdateDate>
          <name>Introduced in House</name>
          <versionCode>00</versionCode>
          <text><![CDATA[<p><b>Alzheimer's Breakthrough Sunshine Act </b></p> <p>This bill amends the Internal Revenue Code to exclude from gross income for seven years amounts received from the sale of certain drugs for treating Alzheimer's disease and related dementias. </p> <p>The exclusion applies to the sale of a drug approved or licensed as a disease-modifying treatment for Alzheimer's disease and that has been designated as a breakthrough therapy under the Federal Food, Drug, and Cosmetic Act. The drug must be sold through an arm's length transaction by a holder of the approved application for the drug. </p>]]></text>
          <updateDate>2016-05-26T04:00:00Z</updateDate>
          <actionDesc>Introduced in House</actionDesc>
        </item>
      </billSummaries>
    </summaries>
    <sponsors>
      <item>
        <bioguideId>M001191</bioguideId>
        <identifiers>
          <bioguideId>M001191</bioguideId>
          <lisID>2117</lisID>
          <gpoId />
        </identifiers>
        <byRequestType />
        <state>FL</state>
        <fullName>Rep. Murphy, Patrick [D-FL-18]</fullName>
        <party>D</party>
        <district>18</district>
        <lastName>Murphy</lastName>
        <firstName>Patrick</firstName>
        <middleName />
      </item>
    </sponsors>
    <amendments />
    <latestAction>
      <actionDate>2016-05-26</actionDate>
      <links />
      <text>Referred to the House Committee on Ways and Means.</text>
    </latestAction>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>hswm00</systemCode>
          <chamber>House</chamber>
          <name>Ways and Means Committee</name>
          <type>Standing</type>
          <subcommittees />
          <activities>
            <item>
              <date>2016-05-26T13:05:00Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Taxation</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Aging</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Income tax exclusion</name>
          </item>
          <item>
            <name>Neurological disorders</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <relatedBills />
    <notes />
    <actions>
      <item>
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committee>
          <systemCode>hswm00</systemCode>
          <name>Ways and Means Committee</name>
        </committee>
        <actionCode>H11100</actionCode>
        <text>Referred to the House Committee on Ways and Means.</text>
        <actionDate>2016-05-26</actionDate>
      </item>
      <item>
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committee />
        <actionCode>Intro-H</actionCode>
        <text>Introduced in House</text>
        <actionDate>2016-05-26</actionDate>
      </item>
      <item>
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committee />
        <actionCode>1000</actionCode>
        <text>Introduced in House</text>
        <actionDate>2016-05-26</actionDate>
      </item>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInHouse>1</introducedInHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <calendarNumbers />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

